Genepharm

Genepharm plans on delivering several new generic products per year to its customers. While GENEPHARM retains its position in the Greek market, having established solid relationships with local physicians and patients, our business extends globally via strategic alliances, based on the development of new products and our continuous investment in state-of-the-art infrastructure and technologies. Greece: manufacturing, sales and marketing of its own branded generic pharmaceutical productsEurope: product development and out-licensing of its product dossiers, research & development, regulatory affairs and intellectual property Worldwide: sales and distribution of own branded generic pharmaceutical products. The company has two dedicated state-of-the-art production facilities located in Athens Greece, designed in accordance with EU cGMP requirements:. To ensure the quality of its products and services Genepharm has invested in a series of processes that are the cornerstone of the company’s success in the Greek and foreign markets. The quality of the products the company produces is also guaranteed by our employees’ level of scientific training and our state-of-the-art manufacturing equipment; the two combined, ensure that our pharmaceuticals are constantly monitored and checked during production and have the quality required for their specified use. Our Quality Control Department controls the production running all necessary checks at every stage, from raw materials to final product, as prescribed by European GMPs, The National Organization for Medicines as well as EMEA & ICH. Having secured agreements for its products with the leading generic companies in Europe and around the world, Genepharm is focused on forging strong and long-lasting relationships with its partners.